Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

1.

Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.

Vasilatos SN, Katz TA, Oesterreich S, Wan Y, Davidson NE, Huang Y.

Carcinogenesis. 2013 Jun;34(6):1196-207. doi: 10.1093/carcin/bgt033. Epub 2013 Jan 25.

PMID:
23354309
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells.

Huang Y, Vasilatos SN, Boric L, Shaw PG, Davidson NE.

Breast Cancer Res Treat. 2012 Feb;131(3):777-89. doi: 10.1007/s10549-011-1480-8. Epub 2011 Mar 31.

PMID:
21452019
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.

Singh MM, Manton CA, Bhat KP, Tsai WW, Aldape K, Barton MC, Chandra J.

Neuro Oncol. 2011 Aug;13(8):894-903. doi: 10.1093/neuonc/nor049. Epub 2011 Jun 8.

PMID:
21653597
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, enhances radiosensitivity and suppresses lung metastasis in breast cancer in vitro and in vivo.

Chiu HW, Yeh YL, Wang YC, Huang WJ, Chen YA, Chiou YS, Ho SY, Lin P, Wang YJ.

PLoS One. 2013 Oct 10;8(10):e76340. doi: 10.1371/journal.pone.0076340. eCollection 2013.

PMID:
24130769
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.

Tate CR, Rhodes LV, Segar HC, Driver JL, Pounder FN, Burow ME, Collins-Burow BM.

Breast Cancer Res. 2012 May 21;14(3):R79.

PMID:
22613095
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Induction of E-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition.

Kakihana M, Ohira T, Chan D, Webster RB, Kato H, Drabkin HA, Gemmill RM.

J Thorac Oncol. 2009 Dec;4(12):1455-65. doi: 10.1097/JTO.0b013e3181bc9419.

PMID:
20009910
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.

Meng F, Sun G, Zhong M, Yu Y, Brewer MA.

Int J Oncol. 2013 Aug;43(2):495-502. doi: 10.3892/ijo.2013.1960. Epub 2013 May 24.

PMID:
23709006
[PubMed - indexed for MEDLINE]
8.

Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.

Feng W, Lu Z, Luo RZ, Zhang X, Seto E, Liao WS, Yu Y.

Int J Cancer. 2007 Apr 15;120(8):1664-8.

PMID:
17230502
[PubMed - indexed for MEDLINE]
9.

E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.

Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.

Oncogene. 2006 Jan 12;25(2):230-9.

PMID:
16158053
[PubMed - indexed for MEDLINE]
10.

Histone demethylase LSD1 regulates neural stem cell proliferation.

Sun G, Alzayady K, Stewart R, Ye P, Yang S, Li W, Shi Y.

Mol Cell Biol. 2010 Apr;30(8):1997-2005. doi: 10.1128/MCB.01116-09. Epub 2010 Feb 1.

PMID:
20123967
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL.

Yerbes R, López-Rivas A.

Invest New Drugs. 2012 Apr;30(2):541-7. doi: 10.1007/s10637-010-9597-x. Epub 2010 Nov 25.

PMID:
21107885
[PubMed - indexed for MEDLINE]
12.

CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status.

Kim HM, Kim CS, Lee JH, Jang SJ, Hwang JJ, Ro S, Hyun YL, Choi J.

Breast Cancer Res Treat. 2011 Nov;130(2):365-75. doi: 10.1007/s10549-010-1310-4. Epub 2010 Dec 24.

PMID:
21184271
[PubMed - indexed for MEDLINE]
13.

Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology.

Lim S, Janzer A, Becker A, Zimmer A, Schüle R, Buettner R, Kirfel J.

Carcinogenesis. 2010 Mar;31(3):512-20. doi: 10.1093/carcin/bgp324. Epub 2009 Dec 30.

PMID:
20042638
[PubMed - indexed for MEDLINE]
Free Article
14.

A new synthetic HDAC inhibitor, MHY218, induces apoptosis or autophagy-related cell death in tamoxifen-resistant MCF-7 breast cancer cells.

Park JH, Ahn MY, Kim TH, Yoon S, Kang KW, Lee J, Moon HR, Jung JH, Chung HY, Kim HS.

Invest New Drugs. 2012 Oct;30(5):1887-98. doi: 10.1007/s10637-011-9752-z. Epub 2011 Oct 8.

PMID:
21983700
[PubMed - indexed for MEDLINE]
15.

Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.

Chen MY, Liao WS, Lu Z, Bornmann WG, Hennessey V, Washington MN, Rosner GL, Yu Y, Ahmed AA, Bast RC Jr.

Cancer. 2011 Oct 1;117(19):4424-38. doi: 10.1002/cncr.26073.

PMID:
21491416
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Lysine-specific histone demethylase 1 inhibitors control breast cancer proliferation in ERα-dependent and -independent manners.

Pollock JA, Larrea MD, Jasper JS, McDonnell DP, McCafferty DG.

ACS Chem Biol. 2012 Jul 20;7(7):1221-31. doi: 10.1021/cb300108c. Epub 2012 May 10.

PMID:
22533360
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL.

Butler LM, Liapis V, Bouralexis S, Welldon K, Hay S, Thai le M, Labrinidis A, Tilley WD, Findlay DM, Evdokiou A.

Int J Cancer. 2006 Aug 15;119(4):944-54.

PMID:
16550602
[PubMed - indexed for MEDLINE]
18.

Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells.

Rao R, Balusu R, Fiskus W, Mudunuru U, Venkannagari S, Chauhan L, Smith JE, Hembruff SL, Ha K, Atadja P, Bhalla KN.

Mol Cancer Ther. 2012 Apr;11(4):973-83. doi: 10.1158/1535-7163.MCT-11-0979. Epub 2012 Feb 24.

PMID:
22367781
[PubMed - indexed for MEDLINE]
Free Article
19.

Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo.

Singh T, Prasad R, Katiyar SK.

Epigenetics. 2013 Jan;8(1):54-65. doi: 10.4161/epi.23078. Epub 2012 Dec 5.

PMID:
23221619
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Curbing autophagy and histone deacetylases to kill cancer cells.

Gammoh N, Marks PA, Jiang X.

Autophagy. 2012 Oct;8(10):1521-2. doi: 10.4161/auto.21151. Epub 2012 Aug 16.

PMID:
22894919
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk